- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
23. Schedule 7 to the PLPS Regulations (mandatory terms for LPS schemes) is amended in accordance with this Part.
24. In paragraph 7(1) (refusal to provide drugs or appliances ordered), in sub-paragraph (2A), after “(or at all)” insert—
“, but where C does so, C must take all reasonable steps to ensure that the product ordered by the prescriber is supplied within a reasonable timescale, which may include (depending on what steps or combination of steps the circumstances require)—
(a)providing details of other LPS chemists or NHS pharmacists whose premises are situated in the same area and who may be able to provide the product ordered by the prescriber;
(b)urgent supply without a prescription in accordance with paragraph 4;
(c)arranging for the urgent provision of a non-electronic prescription form by the prescriber.”.
25. In paragraph 8 (further activities to be carried out in connection with the provision of dispensing services), in sub-paragraph (1)(c), after “written note” insert “(which may be in an electronic form)”.
26. In paragraph 9(2) (additional requirements in relation to electronic prescribing)—
(a)in sub-paragraph (1)—
(i)omit paragraph (a), and
(ii)in paragraph (b), for “not available” substitute “temporarily unavailable”; and
(b)in sub-paragraph (2), omit “Where the Electronic Prescription Service is available through C’s premises ,”.
27. In paragraph 13A(3) (accessing summary care records), for paragraphs (1) and (2) substitute—
“(1) An LPS chemist (C) must have access to summary care records at C’s scheme premises, and must ensure that the access that C has to summary care records at those premises is constant and reliable during the hours when the scheme premises are open to the public, in so far as that is within the control of C.
(2) C must access the summary information in a patient’s summary care record whenever C is providing local pharmaceutical services to the patient, to the extent that C, in the exercise of C’s clinical judgement, considers it appropriate to do so.”.
28. After paragraph 13A (accessing summary care records) insert—
13B. An LPS chemist (C) must have access to the EPS at C’s scheme premises, and must ensure that the access that C has to the EPS at those premises is constant and reliable during the hours when the scheme premises are open to the public, in so far as that is within the control of C.
13C.—(1) An LPS chemist (C) must ensure that pharmacy staff at listed premises (including locums) have access to, and are able to send and receive NHSmail from, a premises specific NHSmail account.
(2) C must ensure that at least two members of the pharmacy staff have live, linked NHSmail accounts to the premises specific NHSmail account (unless fewer than two members of the pharmacy staff are engaged in the provision of NHS services).
(3) As regards the Central Alerting System (CAS) operated by the Medicines and Healthcare products Regulatory Agency(4) (MHRA)—
(a)C must register C’s premises specific NHSmail address with MHRA as an address at which C is content to accept notifications as part of the CAS (unless they are content with the address already in the system);
(b)if C changes C’s premises specific NHSmail address, P must immediately notify MHRA of C’s new premises specific NHSmail address, in accordance with paragraph (a); and
(c)C must monitor C’s premises specific NHSmail account with sufficient frequency to ensure the safe and effective supply of medicinal products at or from C’s pharmacy premises, and must act on the alerts C receives as part of the CAS, as appropriate.”.
Paragraph 7 has been amended by S.I. 2018/1114 and 2019/990.
Amended by S.I. 2018/1114.
Inserted by S.I. 2016/296.
The Medicines and Healthcare products Regulatory Agency is an executive agency of the Department of Health and Social Care. Its address is 10 South Colonnade, Canary Wharf, London E14 4PU.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: